GO:0006360 transcription by RNA polymerase I: Ribosome Biogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006360 describes the synthesis of RNA from a DNA template by RNA polymerase I (RNAP I), originating at an RNAP I promoter [QuickGO definition].
• RNAP I transcription is dedicated to ribosomal RNA (rRNA) production, making it a central determinant of ribosome biogenesis and cell growth.
• The process is tightly regulated and coordinated with rRNA processing to meet cellular demand for protein synthesis.
• Dysregulated RNAP I transcription is a hallmark of cancer and is actively pursued as a therapeutic target [3, 7].
• Species-specific transcription factors and promoter architectures distinguish RNAP I systems across organisms.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of RNAP I transcription components [3, 7].
Description
Transcription by RNA polymerase I (RNAP I) is the biological process responsible for synthesizing ribosomal RNA from a DNA template, initiating at an RNAP I promoter [QuickGO definition]. This process is essential for ribosome biogenesis and therefore for protein synthesis and cell growth. Unlike RNA polymerase II, which transcribes protein-coding genes, RNAP I is dedicated to the large ribosomal RNA precursor, making it a focal point for understanding how cells allocate resources to growth. The term GO:0006360 captures this entire process, from promoter recognition to termination, and is a key ontology node for researchers studying nucleolar function and ribosome production [5, 8]. Researchers care about RNAP I transcription because it is a rate-limiting step in ribosome assembly and is frequently upregulated in cancer cells to sustain rapid proliferation. The process is also subject to species-specific regulation, which has implications for model organism studies and for understanding evolutionary divergence in transcriptional control. In trypanosomes, RNAP I even transcribes protein-coding genes, illustrating the diversity of RNAP I function across eukaryotes. Mechanistically, RNAP I transcription requires a set of basal transcription factors, including TBP, UAF, and SL1, which assemble on the promoter to recruit the polymerase [1, 2]. Termination is also a regulated step, ensuring proper rRNA processing and preventing read-through into adjacent sequences. Understanding these steps at a molecular level is essential for developing targeted therapies that exploit cancer-specific dependencies on rRNA synthesis [3, 7].
transcription by RNA polymerase I At A Glance
| GO ID | GO:0006360 |
|---|---|
| GO term | transcription by RNA polymerase I |
| Ontology | biological_process |
| Synonym | RNA polymerase I transcription factor activity; transcription from Pol I promoter; transcription from RNA polymerase I promoter |
| Major function | Synthesis of ribosomal RNA from a DNA template by RNAP I |
| Cellular location | Nucleolus |
| Key enzyme | RNA polymerase I (RNAP I) |
| Associated factors | TBP, UAF, SL1, TAF1B, etc. |
| Process outcome | Pre-rRNA transcript for ribosome biogenesis |
What Is GO:0006360?
GO:0006360, transcription by RNA polymerase I, is defined as the synthesis of RNA from a DNA template by RNA polymerase I (RNAP I), originating at an RNAP I promoter. This process is responsible for producing the precursor ribosomal RNA that is subsequently processed into mature rRNA components of the ribosome. It is a biological process that occurs primarily in the nucleolus and is distinct from transcription by RNA polymerases II and III.
Why Is transcription by RNA polymerase I Important in Cell Biology?
Transcription by RNA polymerase I is fundamental to cell growth because it supplies the rRNA needed for ribosome assembly. Its dysregulation is linked to cancer, where increased rRNA synthesis supports rapid proliferation, and to developmental disorders. Understanding this process provides insights into basic cell biology and offers therapeutic opportunities for diseases characterized by aberrant ribosome biogenesis [3, 5, 7].
• Drives ribosome biogenesis and protein synthesis capacity.
• Frequently upregulated in cancer to meet high metabolic demand [3, 7].
• Represents a target for cancer therapeutics, with inhibitors in clinical trials.
• Coordinated with rRNA processing to maintain RNA quality control.
• Exhibits species-specific mechanisms, informing model organism choice.
• Involved in nucleolar stress responses and cell cycle regulation.
• Can transcribe protein-coding genes in kinetoplastids, expanding functional repertoire.
• Termination mechanisms prevent read-through and ensure proper rRNA maturation.
• Provides a paradigm for studying transcription factor assembly and promoter selection.
• Links to diseases of ribosome dysfunction (ribosomopathies) and neurodegeneration.
What Happens During transcription by RNA polymerase I?
Promoter recognition and pre-initiation complex assembly
In simple terms: First, a set of proteins recognizes the start site of ribosomal RNA genes and assembles a molecular machine to begin copying DNA into RNA.
RNAP I transcription begins with the recognition of the ribosomal DNA promoter by basal transcription factors. TBP (TATA-binding protein) plays a key role in facilitating RNA Polymerase I transcription following mitosis, helping to reinitiate rRNA synthesis after cell division. The upstream activating factor (UAF) is involved in selecting the correct RNA polymerase I for transcription, ensuring that the polymerase is properly recruited to the promoter. These early steps are critical for establishing a productive initiation complex.
Initiation and elongation
In simple terms: Once the machinery is in place, the enzyme starts moving along the DNA, synthesizing a long RNA copy of the ribosomal RNA gene.
After promoter recognition, RNAP I initiates transcription and transitions to elongation. This phase is highly processive, generating a long precursor rRNA transcript. The coordination between initiation and elongation is essential for matching rRNA production with cellular growth demands. Species-specific factors influence the efficiency of these steps, as different organisms have distinct requirements for RNAP I transcription.
Termination and release
In simple terms: At the end of the gene, the enzyme stops and releases the newly made RNA, which will be further processed into mature ribosomal RNA.
Termination of RNAP I transcription is a regulated process that ensures the RNA transcript is properly released. The mechanism of transcription termination by RNA polymerase I involves specific DNA elements and protein factors that signal the polymerase to stop. Proper termination is crucial for preventing interference with neighboring genes and for efficient rRNA processing.
Coordination with rRNA processing
In simple terms: The long RNA produced is cut and modified into the functional pieces of the ribosome, and this processing is tightly linked to the transcription step.
The precursor rRNA synthesized by RNAP I undergoes extensive processing, including cleavage and modification, to yield mature 18S, 5.8S, and 25S/28S rRNAs. This processing is coordinated with transcription to ensure stoichiometric assembly of ribosomal subunits. Defects in this coordination can lead to ribosome biogenesis stress and disease.
Key Genes Involved in GO:0006360 transcription by RNA polymerase I
The following genes and proteins are central to transcription by RNA polymerase I, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR1A | Catalytic subunit of RNA polymerase I | Target for cancer therapy; knockout reduces rRNA synthesis |
| POLR1B | Second largest subunit of RNAP I | Mutations linked to ribosomopathies; model for point mutation studies |
| POLR1C | Shared subunit of RNAP I and III | Involved in Treacher Collins syndrome; knockout models |
| POLR1D | Shared subunit of RNAP I and III | Associated with craniofacial disorders; CRISPR models |
| TBP | TATA-binding protein, facilitates RNAP I transcription after mitosis | Knockout studies reveal role in reinitiation |
| UAF | Upstream activating factor, selects RNAP I | Structural studies; knockout affects polymerase recruitment |
| SL1 | Core promoter selectivity factor | Essential for initiation; overexpression models |
| TAF1B | Subunit of SL1 complex | Regulates promoter recognition; knockdown reduces rRNA |
| TAF1C | Subunit of SL1 complex | Involved in pre-initiation complex assembly |
| RRN3 | Essential initiation factor | Phosphorylation-regulated; knockout is lethal |
| UBF | Upstream binding factor, architectural protein | Overexpression increases rRNA synthesis |
| LINC01116 | Long non-coding RNA, upregulates RNAP I transcription | Knockdown reduces oncogenic phenotypes in lung adenocarcinoma |
| MYC | Oncogene, stimulates RNAP I transcription | Overexpression models show increased rRNA |
| TP53 | Tumor suppressor, represses RNAP I transcription | Knockout increases rRNA synthesis |
| mTOR | Kinase, activates RNAP I transcription | Inhibitor studies link growth signaling to rRNA |
| CDK9 | Kinase, regulates RNAP I elongation | Inhibitors reduce rRNA synthesis |
| Treacle | Protein involved in RNAP I transcription | Mutations cause Treacher Collins; knockout models |
How Is transcription by RNA polymerase I Regulated?
Transcription by RNA polymerase I is regulated by multiple signaling pathways, including mTOR, which promotes rRNA synthesis in response to growth factors. The process is also cell-cycle regulated, with TBP facilitating reinitiation after mitosis. Oncogenes such as MYC enhance RNAP I transcription, while tumor suppressors like p53 repress it. Additionally, long non-coding RNAs such as LINC01116 can upregulate RNAP I transcription in cancer. Species-specific factors further modulate the efficiency of transcription.
transcription by RNA polymerase I and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLR1A | Cancer (multiple types) | Knockout and overexpression in cancer cell lines |
| POLR1C | Treacher Collins syndrome | Point mutation knock-in in zebrafish or mouse |
| LINC01116 | Lung adenocarcinoma | Knockdown and overexpression in A549 cells |
| MYC | Burkitt lymphoma and other cancers | Transgenic overexpression models |
| TP53 | Li-Fraumeni syndrome and cancers | Knockout in cell lines and organoids |
Cancer
Dysregulated RNAP I transcription is a hallmark of many cancers, supporting the high demand for ribosomes in proliferating cells. Targeting RNAP I transcription has emerged as a promising therapeutic strategy, with inhibitors showing efficacy in preclinical models. In lung adenocarcinoma, the long non-coding RNA LINC01116 upregulates RNAP I transcription, driving oncogenic phenotypes.
Ribosomopathies
Mutations in genes encoding RNAP I subunits or associated factors can cause ribosomopathies, such as Treacher Collins syndrome, characterized by craniofacial abnormalities and developmental defects. These disorders highlight the importance of precise regulation of rRNA synthesis during development.
Neurodegeneration
Altered nucleolar function and RNAP I transcription have been implicated in neurodegenerative diseases, although the exact mechanisms remain under investigation. Further research is needed to establish causal links.
From transcription by RNA polymerase I-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of POLR1A reduce rRNA synthesis? | Knockout cell lines (e.g., CRISPR-Cas9) |
| Does a specific POLR1B mutation cause ribosomopathy? | Point mutation knock-in in zebrafish |
| Can tagged UAF be used to study promoter selection? | Knock-in of epitope tag at endogenous locus |
| Does LINC01116 overexpression drive oncogenesis? | Overexpression in lung cancer cell lines |
| Is TBP required for post-mitotic RNAP I reinitiation? | Inducible knockout of TBP |
| Does mTOR inhibition affect RNAP I transcription? | Pharmacological inhibition in cell culture |
How to Study the transcription by RNA polymerase I Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | rRNA precursor and mature rRNA levels | Assessing RNAP I activity after knockout |
| ChIP-seq | Occupancy of RNAP I and factors on rDNA | Mapping initiation sites |
| EU labeling | Nascent RNA synthesis | Measuring transcription rates |
| Mass spectrometry | Protein-protein interactions | Identifying novel complex components |
| Northern blot | Specific rRNA species | Validating processing defects |
| qRT-PCR | rRNA transcript levels | High-throughput screening |
| CRISPR screening | Gene essentiality for rRNA synthesis | Identifying regulators |
| Live-cell imaging | Nucleolar dynamics | Visualizing transcription sites |
RNA-seq and rRNA profiling
RNA sequencing can quantify rRNA precursors and mature rRNA levels, providing a readout of RNAP I transcription activity. This method is useful for assessing changes in response to genetic perturbations.
Chromatin immunoprecipitation (ChIP)
ChIP with antibodies against RNAP I subunits or transcription factors can determine occupancy at ribosomal DNA promoters, revealing mechanisms of initiation and elongation [1, 2].
Metabolic labeling
Labeling newly synthesized RNA with uridine analogs (e.g., EU) allows direct measurement of RNAP I transcription rates in live cells.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify protein complexes associated with RNAP I transcription factors, uncovering novel regulators.
How CRISPR Can Be Used to Study GO:0006360 transcription by RNA polymerase I
Knockout
CRISPR knockout of RNAP I subunits or transcription factors (e.g., POLR1A, TBP) can abolish rRNA synthesis, revealing essential roles in cell proliferation and survival [1, 3].
Point Mutation
Introducing specific point mutations (e.g., in POLR1B or POLR1C) via CRISPR can model ribosomopathies and dissect the impact of disease-associated variants on RNAP I function.
Knock-in
Knock-in of epitope tags or fluorescent reporters at endogenous loci (e.g., UAF, SL1 subunits) enables real-time tracking and biochemical purification of transcription complexes.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of factors like MYC or LINC01116 can drive RNAP I transcription, modeling oncogenic states [3, 7].
How EDITGENE Supports transcription by RNA polymerase I Research
Researchers studying transcription by RNA polymerase I-related genes often need to determine whether a candidate gene is causally involved in rRNA synthesis, ribosome biogenesis, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for transcription by RNA polymerase I research.
Frequently Asked Questions About transcription by RNA polymerase I
What is transcription by RNA polymerase I?
Transcription by RNA polymerase I is the synthesis of ribosomal RNA from a DNA template by RNA polymerase I, starting at an RNAP I promoter [QuickGO definition].
What genes are involved in transcription by RNA polymerase I?
Key genes include POLR1A, POLR1B, POLR1C, POLR1D, TBP, UAF, SL1 subunits, RRN3, UBF, and MYC [1, 2, 3, 5].
What is the GO ID for transcription by RNA polymerase I?
The Gene Ontology ID is GO:0006360.
How is RNA polymerase I transcription regulated?
It is regulated by signaling pathways such as mTOR, cell cycle cues, oncogenes like MYC, and tumor suppressors like p53 [1, 3].
Why is RNA polymerase I transcription important in cancer?
Cancer cells often upregulate RNAP I transcription to meet increased ribosome demand, making it a therapeutic target [3, 7].
What diseases are associated with defects in RNA polymerase I transcription?
Diseases include ribosomopathies like Treacher Collins syndrome and various cancers.
What methods are used to study RNA polymerase I transcription?
Common methods include RNA-seq, ChIP, metabolic labeling, and CRISPR screens [1, 2, 3, 5].
Can CRISPR be used to study RNA polymerase I transcription?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function [1, 2, 3, 7].
What is the role of TBP in RNA polymerase I transcription?
TBP facilitates RNA Polymerase I transcription following mitosis, aiding reinitiation.
How does UAF contribute to RNA polymerase I transcription?
UAF is involved in selecting RNA polymerase I for transcription, ensuring proper recruitment.
Conclusion
Transcription by RNA polymerase I (GO:0006360) is a fundamental biological process that drives ribosome biogenesis and cell growth. Its dysregulation is implicated in cancer and developmental disorders, making it a compelling target for therapeutic intervention. Advances in CRISPR-based models and high-throughput methods continue to unravel the complex regulation of this process, offering new opportunities for research and drug discovery [3, 5, 7].
References
- 1. Kwan JZJ et al.. 2024. TBP facilitates RNA Polymerase I transcription following mitosis.. RNA Biol 21(1):42-51 PMID: 38958280
- 2. Baudin F et al.. 2022. Mechanism of RNA polymerase I selection by transcription factor UAF.. Sci Adv 8(16):eabn5725 PMID: 35442737
- 3. Ferreira R et al.. 2020. Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age.. Cells 9(2) PMID: 31973211
- 4. Lee MG et al.. 1997. Transcription of protein-coding genes in trypanosomes by RNA polymerase I.. Annu Rev Microbiol 51:463-89 PMID: 9343357
- 5. Scull CE et al.. 2019. Coordinated Control of rRNA Processing by RNA Polymerase I.. Trends Genet 35(10):724-733 PMID: 31358304
- 6. Heix J et al.. 1995. Species specificity of transcription by RNA polymerase I.. Curr Opin Genet Dev 5(5):652-6 PMID: 8664554
- 7. Sarkar SS et al.. 2024. LINC01116-dependent upregulation of RNA polymerase I transcription drives oncogenic phenotypes in lung adenocarcinoma.. J Transl Med 22(1):904 PMID: 39369230
- 8. Reeder RH et al.. 1994. The mechanism of transcription termination by RNA polymerase I.. Mol Microbiol 12(1):11-5 PMID: 8057832
